A phase I, open‐label, single‐dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib

por Gao, Ling, Yamamiya, Ikuo, Pinti, Mark, Rondon, Juan Carlos, Marbury, Thomas, Tomlinson, Gareth, Makris, Lukas, Hangai, Nanae, Wacheck, Volker
Publicado 2023